Literature DB >> 22957404

Acute myeloid leukemia with adverse cytogenetic risk.

Krzysztof Mrózek1, Clara D Bloomfield.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22957404      PMCID： PMC3831632     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  18 in total

1.  Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.

Authors:  Krzysztof Mrózek; Kristiina Heinonen; Karl S Theil; Clara D Bloomfield
Journal:  Genes Chromosomes Cancer       Date:  2002-06       Impact factor: 5.006

2.  Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.

Authors:  Christoph Röllig; Martin Bornhäuser; Christian Thiede; Franziska Taube; Michael Kramer; Brigitte Mohr; Walter Aulitzky; Heinrich Bodenstein; Hans-Joachim Tischler; Reingard Stuhlmann; Ulrich Schuler; Friedrich Stölzel; Malte von Bonin; Hannes Wandt; Kerstin Schäfer-Eckart; Markus Schaich; Gerhard Ehninger
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

Review 3.  Independent prognostic variables in acute myeloid leukaemia.

Authors:  Matthew L Smith; Robert K Hills; David Grimwade
Journal:  Blood Rev       Date:  2010-11-27       Impact factor: 8.250

Review 4.  Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.

Authors:  Krzysztof Mrózek
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

5.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

6.  Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.

Authors:  Betul Oran; Michelle Dolan; Qing Cao; Claudio Brunstein; Erica Warlick; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-27       Impact factor: 5.742

Review 7.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.

Authors:  Dimitri A Breems; Wim L J Van Putten; Georgine E De Greef; Shama L Van Zelderen-Bhola; Klasien B J Gerssen-Schoorl; Clemens H M Mellink; Aggie Nieuwint; Martine Jotterand; Anne Hagemeijer; H Berna Beverloo; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2008-08-11       Impact factor: 44.544

Review 10.  Cytogenetics in acute leukemia.

Authors:  Krzysztof Mrózek; Nyla A Heerema; Clara D Bloomfield
Journal:  Blood Rev       Date:  2004-06       Impact factor: 8.250
View more
  1 in total

1.  Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

Authors:  Jae-Ho Yoon; Hee-Je Kim; Seung-Hwan Shin; Seung-Ah Yahng; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chong-Won Park
Journal:  Int J Hematol       Date:  2013-04-25       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.